INCATE is supporting a startup competition at the AMRCONFERNCE on April 7th. You will have the chance to pitch in front of industry and investors and win a 10k EUR prize from award sponsor Vossius, one of the leading IP law firms in Europe and Switzerland. Apply by January 31st at https://amr-conference.com/start-ups-amr-conference-pitching-session/ or here
More info below
Early-stage ventures fighting AMR wanted!
The start-up competition @AMR conference supported by INCATE has started.
Early-stage ventures fighting drug resistant bacterial infections in the therapeutics or diagnostics area interested to be on stage are invited to apply now!
The official application process for the Start-up competition @AMR Conference 2022 has started. Early-stage ventures fighting drug resistant bacterial infections in the therapeutics or diagnostics area are invited to apply until 31 January 2022 for a pitch during the AMR Conference 2022 taking place from 7-8 April in the Congress Center in Basel, Switzerland.
10 finalists on stage
10 finalists will receive the opportunity to make a 5-minute-pitch in front of potential funders and investors during the start-up pitch session schedule for April 7. Investors, science and industry experts will be part of the jury and nominate the best pitch which will receive a prize.
INCATE is main partner of the competition
The start-up competition is supported by INCATE and further partners from the international AMR community. INCATE brings together translational and basic research, industry, experienced entrepreneurs and investors from across Europe to accelerate innovation in the AMR community. It particularly aims at bridging the gap between basic research and industrial implementation of new antibacterial treatment options by pooling resources and competences. The German Center for Infection Research (DZIF), the research association InfectControl in Germany, the Swiss National Centre of Competence in Research AntiResist and the University of Basel are the academic founding members of INCATE. Together with the four pharma companies Boehringer Ingelheim, Roche, Shionogi and MSD as well as other organizations, funders and investors, they want to ensure that the pipeline of new antibiotics and diagnostics is filled and strengthened. Expert advice, building of a community supporting venture development and targeted funding are the three tools with which INCATE aims to achieve this goal. (More information at www.incate.net)
Selection of finalists to be announced in February 2022
The final selection of the TOP TEN applicants of the start-up competition will be made in February 2022. All companies selected for participation will receive a free entrance to the AMR conference 2022, the 1-to-1 partnering platform and the session participation as a speaker for one team member.
“The start-up competition provides an ideal opportunity to gain attention among relevant investors and funders”, says Helmut Kessmann, responsible for industry contacts at INCATE.
“The AMR Conference 2022 offers founders and young entrepreneurs a well-established platform to get connected with the international AMR community. Being on stage will boost visibility among potential supporters in industry and finance”, says Sandra Wirsching, AMR Conference program lead.
About the AMR Conference
More than 400 experts from across the international AMR community are expected to join for the 6th AMR Conference 2022, taking place from 7-8 April in the Congress Center in Basel, Switzerland. The event is organized by Berlin-based BIOCOM AG with the support of SME organization BEAM Alliance. It brings together top-level experts from business, science, clinics, finance, regulatory affairs and intellectual property to discuss business strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.
VOSSIUS is one of Europe’s leading intellectual property firms, serving an international clientele. The about 350 employees of the firm specialize in intellectual property. Clients include large and mid-sized companies in Europe, Switzerland and abroad, academic and scientific institutions, as well as start-ups. With decades of expertise the firm provides high-end advice for innovative companies in all questions relating to intellectual property